For the next four years, California's public hospitals will collectively receive up to $472 million annually to cover hospital visits for the uninsured as part of a waiver meant to reform the state's Medicaid program.
Humana will scale back its presence in the Affordable Care Act's exchanges in 2017, selling individual plans in 11 states compared with 19 states this year.
An insurance company will have to cover a pharmaceutical distributor's defense costs in a West Virginia lawsuit attempting to hold it and others liable for the state's prescription drug abuse epidemic, a federal appeals court has ruled.
Pharmaceutical giant AstraZeneca failed to block approval of generics for its best-selling cholesterol drug after a federal judge tossed out the company's request.
HCA's East Florida division will invest about $650 million in its facilities, including a $219 million hospital.
The court's term that ended late last month wasn't nearly so straightforward for the industry. At least half a dozen notable cases left some people cheering and others wringing their hands. And the midterm death of Justice Antonin Scalia appears to have affected some of the outcomes.
Senate Finance Committee Chairman Orrin Hatch will lead a hearing Tuesday on ways to change the Stark law following a congressional report that said the statute has created “a minefield for the healthcare industry.”
A California-based behavioral health provider is suing Health Net for $55 million, saying the insurer has launched an attack on the industry by refusing to reimburse behavioral health providers for services.
The Obama administration suffered a setback in its efforts to strengthen the individual insurance market when a federal appeals court last week struck down an HHS rule barring the sale of certain limited-benefit plans as stand-alone products.
This year was a mixed bag for healthcare at the Supreme Court, which wrapped up its latest term last week. At least half a dozen notable cases fragmented healthcare wonks' attention. The outcomes of some of those cases left parts of the industry cheering and other parts wringing their hands.
A recently filed lawsuit alleging that a faulty electronic health record system caused patient harm may be among the first in a wave of such cases, even though most experts say the latest EHR systems are better designed than older models.
In deciding a case over who should have the upper hand in patent battles, the U.S. Supreme Court delivered a win to generic-drug makers and those hoping to hold down drug prices.